Which hedge funds own NVCR? NOVOCURE LTD, Q2 2026 13F holders
Healthcare · Open on the interactive board
7 of the hedge funds tracked by WhaleCreep disclosed a position in NVCR (NOVOCURE LTD) in their Q2 2026 13F filings, worth $75.4m in total. The largest holder by portfolio weight is Renaissance Technologies LLC at 0.0% of its book. 1 exited: Ancora Advisors.
7tracked managers holding
0opened this quarter
1exited this quarter
Which hedge funds hold NVCR? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $29.6m | 1,951,911 | 26% | added |
| Point72 Asset Management LP | Q2 2026 | 0.0% | $12.2m | 803,120 | -41% | reduced |
| Tudor Investment | Q2 2026 | 0.0% | $4.1m | 269,027 | 21% | added |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $15.5m | 1,022,480 | 58% | added |
| Baillie Gifford | Q2 2026 | 0.0% | $7.5m | 952,074 | -11% | reduced |
| Millennium Management | Q2 2026 | 0.0% | $4.2m | 278,068 | 205% | added |
| Citadel Advisors | Q2 2026 | 0.0% | $2.4m | 157,235 | 83% | added |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Ancora Advisors | 0.0% | $8.2k |
How has hedge fund ownership of NVCR changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 7 | $75.4m |
| Q1 2026 | 8 | $54.8m |
| Q4 2025 | 6 | $57.3m |
| Q3 2025 | 4 | $38.0m |
| Q2 2025 | 5 | $57.6m |
| Q1 2025 | 5 | $44.2m |
| Q4 2024 | 5 | $75.7m |
| Q3 2024 | 6 | $40.6m |
| Q2 2024 | 6 | $49.3m |
| Q1 2024 | 7 | $74.6m |
| Q4 2023 | 8 | $92.0m |
| Q3 2023 | 6 | $125.2m |
| Q2 2023 | 5 | $368.5m |
| Q1 2023 | 3 | $579.8m |
| Q4 2022 | 4 | $684.7m |
| Q3 2022 | 3 | $759.6m |
Counts every tracked manager that disclosed NVCR in that quarter's filing, including managers that have since stopped filing.